Tnnt3 Antibody

What is TNNT3 and why is it significant in muscle research?

TNNT3 (troponin T type 3) is a fast skeletal muscle protein that serves as a key component of the troponin complex involved in muscle contraction. It plays a critical role in proper muscle function, making it an important target for research investigating skeletal muscle physiology and pathology. Mutations in the TNNT3 gene have been associated with various muscle disorders and developmental conditions, particularly distal arthrogryposis (DA), a group of rare developmental disorders characterized by multiple congenital contractures of the distal limbs . TNNT3 antibodies allow researchers to visualize and analyze TNNT3 expression in different cell types and tissues, providing valuable insights into muscle-related conditions and normal physiology.

What species reactivity can I expect from commercially available TNNT3 antibodies?

The species reactivity of TNNT3 antibodies varies by product, but many commercially available antibodies show reactivity with multiple species. Based on available research antibodies, common reactivity patterns include:

When selecting an antibody for your research, it's crucial to verify the specific reactivity profile for your species of interest and validate the antibody in your experimental system before proceeding with full-scale experiments.

What is the molecular weight of TNNT3 protein and how does this affect antibody selection?

TNNT3 has a calculated molecular weight of approximately 32 kDa, but it typically appears at 35-40 kDa on Western blots . This variation between calculated and observed molecular weight is important to consider when analyzing Western blot results. The specific antibody 19729-1-AP detects TNNT3 at 35-40 kDa , while CAB15323 antibody detects it at approximately 37 kDa . These differences in observed molecular weight may be due to post-translational modifications or isoform variations. When selecting an antibody, researchers should choose one validated to detect the specific isoform or variant of interest in their experimental system.

What are the optimal applications for TNNT3 antibodies?

Different TNNT3 antibodies are optimized for specific applications. Based on the validated applications from commercial sources:

For optimal results, it is recommended to titrate these antibodies in each testing system as the optimal dilution can be sample-dependent . Additionally, some antibodies have been validated for specific combinations of applications and sample types, such as the 19729-1-AP antibody which has been positively detected in rat and mouse skeletal muscle tissue for WB, and in mouse and human skeletal muscle tissue for IHC .

What is the recommended protocol for using TNNT3 antibodies in immunohistochemistry?

For immunohistochemistry with TNNT3 antibodies, follow these methodological steps for optimal results:

• Tissue preparation: Fix tissues appropriately and create sections at optimal thickness (typically 4-6 μm).

• Antigen retrieval: For the 19729-1-AP antibody, suggested antigen retrieval is with TE buffer pH 9.0, though citrate buffer pH 6.0 may also be used as an alternative .

• Antibody dilution: Dilute primary antibody to 1:500-1:2000 .

• Incubation conditions: Optimize temperature and duration according to specific protocol (typically overnight at 4°C).

• Detection system: Use an appropriate secondary antibody and visualization system compatible with your primary antibody.

• Controls: Always include positive controls (skeletal muscle tissue) and negative controls (omission of primary antibody).

For specific tissues, human and mouse skeletal muscle tissues have been positively detected using the 19729-1-AP antibody .

How should I optimize Western blotting protocols for TNNT3 detection?

For optimal Western blot results with TNNT3 antibodies, consider these methodological adjustments:

• Sample preparation: Extract proteins from skeletal muscle tissue, which has shown positive detection with multiple TNNT3 antibodies .

• Loading amount: Optimize protein loading (typically 20-40 μg total protein).

• Separation: Use 10-12% SDS-PAGE gels for optimal resolution around the 35-40 kDa range where TNNT3 is detected.

• Transfer conditions: Optimize transfer time and voltage for proteins in this molecular weight range.

• Blocking: Use 5% non-fat milk or BSA in TBST.

• Antibody dilution: For 19729-1-AP, use 1:500-1:2000 dilution ; for CAB15323, use 1:200-1:2000 dilution .

• Detection: Choose a detection system with appropriate sensitivity for your expected expression level.

• Expected band size: Look for bands at 35-40 kDa, which is the observed molecular weight for TNNT3, despite its calculated molecular weight of 32 kDa .

What are the most common issues when using TNNT3 antibodies and how can they be resolved?

When working with TNNT3 antibodies, researchers may encounter several common issues:

• Weak or no signal:

  • Ensure proper sample preparation from skeletal muscle tissue where TNNT3 is abundantly expressed

  • Increase antibody concentration or incubation time

  • Verify antigen retrieval method (for IHC, try TE buffer pH 9.0 or citrate buffer pH 6.0)

  • Check antibody storage conditions (store at -20°C for stability)

• Multiple bands or non-specific binding:

  • Increase antibody dilution (1:1000-1:2000)

  • Optimize blocking conditions

  • Ensure sufficient washing steps

  • Verify antibody specificity for your species of interest

• Inconsistent results between experiments:

  • Standardize protein extraction and quantification methods

  • Prepare aliquots of antibody to avoid freeze-thaw cycles

  • Maintain consistent incubation times and temperatures

  • Use the same lot number of antibody when possible for critical experiments

• Degradation of signal over time:

  • Store antibody according to manufacturer recommendations (e.g., at -20°C with 50% glycerol)

  • Avoid repeated freeze-thaw cycles by making small aliquots

  • Use freshly prepared buffers and reagents

How should TNNT3 antibodies be stored to maintain optimal activity?

Proper storage of TNNT3 antibodies is crucial for maintaining their activity and specificity:

• Temperature: Store at -20°C as recommended by manufacturers .

• Buffer conditions: Many TNNT3 antibodies are supplied in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 .

• Stability: When properly stored, these antibodies are typically stable for one year after shipment .

• Aliquoting: For the 19729-1-AP antibody, aliquoting is noted as unnecessary for -20°C storage, but it's generally good practice to minimize freeze-thaw cycles for all antibodies .

• BSA content: Some preparations (20μl sizes) contain 0.1% BSA for additional stability .

• Working solution: For short-term use, diluted antibody can be stored at 4°C for up to one week, but longer storage should be at -20°C.

Following these storage recommendations will help ensure consistent performance across experiments and maximize the usable lifetime of your antibody.

What controls should be included when validating a new TNNT3 antibody?

When validating a new TNNT3 antibody for your research, include these essential controls:

• Positive tissue controls:

  • Skeletal muscle tissue (rat, mouse, or human depending on your species of interest) where TNNT3 is known to be expressed

  • The antibody 19729-1-AP has been positively tested in rat and mouse skeletal muscle for WB, and mouse and human skeletal muscle for IHC

• Negative tissue controls:

  • Tissues known not to express TNNT3 or expressing very low levels

  • Non-muscle tissues for comparison

• Technical controls:

  • Antibody omission control (no primary antibody)

  • Isotype control (irrelevant antibody of the same isotype)

  • Concentration gradient to determine optimal working dilution

  • Multiple detection methods if possible (WB, IHC, etc.)

• Specificity validation:

  • If available, use tissues or cells with TNNT3 knockdown/knockout

  • Blocking peptide competition assay using the immunogen peptide

  • For ABIN2784497, consider using the synthetic peptide directed towards the N-terminal region of human TNNT3 used as the immunogen

How can TNNT3 antibodies be utilized to study distal arthrogryposis (DA) mutations?

TNNT3 antibodies play a crucial role in investigating the molecular mechanisms of distal arthrogryposis (DA) caused by TNNT3 mutations:

• Expression level analysis: Research has shown that TNNT3 protein levels in affected family members with the p.R63C variant were 0.8-fold higher than in unaffected individuals . TNNT3 antibodies can be used in Western blotting to quantify such differences in expression levels between normal and mutant proteins.

• Subcellular localization studies: Immunofluorescence with TNNT3 antibodies can reveal altered localization patterns. The p.R63C variant has been shown to promote nuclear accumulation of TNNT3, which may contribute to DA pathogenesis .

• Protein stability assessment: The p.R63C variant significantly prolonged the half-life of TNNT3 from 2.5 to 7 hours . Researchers can use TNNT3 antibodies in conjunction with protein synthesis inhibitors (like cycloheximide) to track degradation rates of normal versus mutant proteins.

• Protein-protein interaction studies: Immunoprecipitation with TNNT3 antibodies can help identify altered interactions between mutant TNNT3 and other muscle proteins, potentially revealing pathogenic mechanisms.

• Therapeutic intervention assessment: TNNT3 antibodies can be used to monitor the effectiveness of experimental therapies aimed at normalizing TNNT3 levels or localization in models of DA.

What are the considerations when using TNNT3 antibodies in multiplex immunostaining experiments?

When designing multiplex immunostaining experiments involving TNNT3 antibodies, researchers should consider:

• Antibody compatibility:

  • Host species: Choose primary antibodies raised in different host species to avoid cross-reactivity

  • For example, TNNT3 antibodies are available in rabbit (19729-1-AP , ABIN2784497 ) and can be paired with antibodies from mouse, goat, or other species

• Fluorophore selection:

  • Choose fluorophores with minimal spectral overlap

  • Consider the relative expression levels of targets (use brighter fluorophores for lower-expressed proteins)

• Antigen retrieval optimization:

  • Different antibodies may require different antigen retrieval methods

  • For TNNT3 (19729-1-AP), TE buffer pH 9.0 is recommended, though citrate buffer pH 6.0 may also work

  • Ensure that retrieval conditions are compatible with all antibodies in your panel

• Sequential staining considerations:

  • If antibodies require incompatible conditions, consider sequential staining protocols

  • Test for potential cross-reactivity between detection systems

• Controls for multiplex staining:

  • Single-color controls to establish proper signal separation

  • Absorption controls to verify specificity in the multiplex context

  • Isotype controls for each primary antibody species

How can TNNT3 antibodies contribute to understanding muscle fiber type-specific expression patterns?

TNNT3 antibodies are valuable tools for investigating muscle fiber type composition and specialized expression patterns:

• Fiber type identification:

  • TNNT3 is primarily expressed in fast-twitch (type II) muscle fibers

  • TNNT3 antibodies can be used to identify fast-twitch fibers in muscle sections

  • Co-staining with antibodies against slow-twitch markers (like TNNT1) allows complete fiber typing

• Developmental regulation:

  • TNNT3 antibodies can track changes in fiber type composition during development

  • Useful for studying the transition from embryonic to adult isoforms of troponin

• Pathological changes:

  • Changes in TNNT3 expression can indicate fiber type switching in disease states

  • Particularly relevant in muscle wasting disorders, disuse atrophy, and training adaptations

• Quantitative analysis:

  • Image analysis of TNNT3 immunostaining can provide quantitative data on:

    • Percentage of fast-twitch fibers

    • Fiber cross-sectional area

    • Intensity of TNNT3 expression (indicating potential adaptations)

• Regional variation assessment:

  • Different skeletal muscles have varying compositions of fiber types

  • TNNT3 antibodies can map these differences across muscle groups

  • Particularly valuable in comparative studies between species or in disease models

How are TNNT3 antibodies being utilized in the investigation of muscular adaptations to exercise and aging?

TNNT3 antibodies are increasingly being applied to understand how skeletal muscle adapts to exercise stimuli and aging processes:

What are the considerations when using TNNT3 antibodies in single-cell analysis techniques?

As single-cell analysis techniques become more prevalent in muscle research, TNNT3 antibodies present both opportunities and challenges:

• Single-cell immunostaining:

  • TNNT3 antibodies can identify fast-twitch muscle cells in heterogeneous cell populations

  • Optimal dilution may differ from tissue section immunostaining (typically more concentrated)

  • Permeabilization protocols may need optimization for intracellular TNNT3 detection

• Flow cytometry considerations:

  • TNNT3 is an intracellular protein requiring effective permeabilization

  • Antibody validation specifically for flow applications is essential

  • Consider fixation method impacts on epitope accessibility

  • Use recommended dilutions as starting points (1:500-1:2000) , but optimize for flow cytometry

• Single-cell Western blotting:

  • Emerging technique allowing protein analysis at single-cell level

  • TNNT3 antibodies must be highly specific with minimal background

  • Sensitivity may be a challenge given the dilution of protein in single-cell preparations

• Mass cytometry (CyTOF) applications:

  • Requires metal-conjugated antibodies

  • Custom conjugation of validated TNNT3 antibodies may be necessary

  • Panel design must account for potential signal spillover

• Validation requirements:

  • More stringent validation needed for single-cell techniques

  • Include positive controls (isolated fast-twitch muscle cells)

  • Use multiple antibodies targeting different epitopes when possible for confirmation

How can protein degradation studies with TNNT3 antibodies inform our understanding of muscle-related diseases?

TNNT3 antibodies provide valuable insights into protein turnover dynamics relevant to muscle disorders:

• Half-life determination:

  • Research has demonstrated that the wild-type TNNT3 protein has a half-life of approximately 2.5 hours, while the disease-associated p.R63C variant shows an extended half-life of 7 hours

  • Similar approaches can be applied to study protein stability in other pathological conditions

• Degradation pathway identification:

  • TNNT3 can be degraded by the ubiquitin-proteasome complex

  • TNNT3 antibodies in combination with proteasome inhibitors can help determine the contribution of different degradation pathways

• Methodological approach:

  • Cycloheximide chase assays with TNNT3 antibody detection

  • Pulse-chase experiments with metabolic labeling

  • Co-immunoprecipitation with ubiquitin or autophagy markers

• Disease relevance:

  • In distal arthrogryposis, altered TNNT3 stability contributes to pathological nuclear accumulation

  • Similar mechanisms may operate in other muscle disorders

  • TNNT3 antibodies can track such abnormal accumulation or degradation patterns

• Therapeutic implications:

  • Identifying compounds that normalize TNNT3 turnover in disease states

  • Monitoring treatment efficacy using TNNT3 antibodies to assess protein levels and localization

  • Screening approaches for drugs affecting TNNT3 stability or degradation

By employing these advanced applications of TNNT3 antibodies, researchers can gain deeper insights into normal muscle physiology and pathological conditions affecting skeletal muscle function.